ARADIGM CORP·4

Apr 6, 1:06 PM ET

ARADIGM CORP 4

4 · ARADIGM CORP · Filed Apr 6, 2017

Insider Transaction Report

Form 4
Period: 2017-04-04
Froehlich Juergen Kurt
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2017-04-04$1.51/sh3,765$5,68585,129 total
Footnotes (2)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2016.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.50 to $1.54 per share and is rounded up to the next whole number. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT